806 related articles for article (PubMed ID: 22673743)
21. Lymphocyte adhesion molecules in autoimmune rheumatic diseases: basic issues and clinical expectations.
Sfikakis PP; Tsokos GC
Clin Exp Rheumatol; 1995; 13(6):763-77. PubMed ID: 8835253
[TBL] [Abstract][Full Text] [Related]
22. [Physiopathologic relationship between interstitial cystitis and rheumatic, autoimmune, and chronic inflammatory diseases].
Lorenzo Gómez MF; Gómez Castro S
Arch Esp Urol; 2004; 57(1):25-34. PubMed ID: 15119315
[TBL] [Abstract][Full Text] [Related]
23. The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia.
Hahn BH; Grossman J; Chen W; McMahon M
J Autoimmun; 2007; 28(2-3):69-75. PubMed ID: 17433865
[TBL] [Abstract][Full Text] [Related]
24. The role of semaphorins in immune responses and autoimmune rheumatic diseases.
Nishide M; Kumanogoh A
Nat Rev Rheumatol; 2018 Jan; 14(1):19-31. PubMed ID: 29213125
[TBL] [Abstract][Full Text] [Related]
25. [Rheumatoid arthritis, inflammation, and atherosclerosis].
Hürlimann D; Enseleit F; Ruschitzka F
Herz; 2004 Dec; 29(8):760-8. PubMed ID: 15599672
[TBL] [Abstract][Full Text] [Related]
26. β2-glycoprotein I and oxidative inflammation in early atherogenesis: a progression from innate to adaptive immunity?
Matsuura E; Lopez LR; Shoenfeld Y; Ames PR
Autoimmun Rev; 2012 Dec; 12(2):241-9. PubMed ID: 22569463
[TBL] [Abstract][Full Text] [Related]
27. Vaccination, atherosclerosis and systemic lupus erythematosus.
Carvalho JF; Pereira RM; Shoenfeld Y
Lupus; 2009 Nov; 18(13):1209-12. PubMed ID: 19880570
[TBL] [Abstract][Full Text] [Related]
28. Malignancies in autoimmune rheumatic diseases - a mini-review.
Szekanecz Z; Szekanecz E; Bakó G; Shoenfeld Y
Gerontology; 2011; 57(1):3-10. PubMed ID: 20453490
[TBL] [Abstract][Full Text] [Related]
29. Human leukocyte antigens class II genes are associated with cancer development in the autoimmune rheumatic diseases.
Miranda-Duarte A; Kraus-Weisman A; Granados J; Vill AR
Rev Invest Clin; 2011; 63(3):236-43. PubMed ID: 21888287
[TBL] [Abstract][Full Text] [Related]
30. The role of phospholipid oxidation products in inflammatory and autoimmune diseases: evidence from animal models and in humans.
Leitinger N
Subcell Biochem; 2008; 49():325-50. PubMed ID: 18751917
[TBL] [Abstract][Full Text] [Related]
31. Autoimmune, rheumatic, chronic inflammatory diseases: Neutrophil extracellular traps on parade.
Podolska MJ; Mahajan A; Knopf J; Hahn J; Boeltz S; Munoz L; Bilyy R; Herrmann M
Autoimmunity; 2018 Sep; 51(6):281-287. PubMed ID: 30369262
[TBL] [Abstract][Full Text] [Related]
32. Atherosclerosis: Beyond the lipid storage hypothesis. The role of autoimmunity.
Cinoku II; Mavragani CP; Moutsopoulos HM
Eur J Clin Invest; 2020 Feb; 50(2):e13195. PubMed ID: 31868918
[TBL] [Abstract][Full Text] [Related]
33. Practical use of immunosuppressive drugs in autoimmune rheumatic diseases.
De Jesus A; Talal N
Crit Care Med; 1990 Feb; 18(2 Suppl):S132-7. PubMed ID: 2298028
[TBL] [Abstract][Full Text] [Related]
34. Cytokine networking of innate immunity cells: a potential target of therapy.
Striz I; Brabcova E; Kolesar L; Sekerkova A
Clin Sci (Lond); 2014 May; 126(9):593-612. PubMed ID: 24450743
[TBL] [Abstract][Full Text] [Related]
35. Pathogenesis of spondyloarthritis: autoimmune or autoinflammatory?
Ambarus C; Yeremenko N; Tak PP; Baeten D
Curr Opin Rheumatol; 2012 Jul; 24(4):351-8. PubMed ID: 22488076
[TBL] [Abstract][Full Text] [Related]
36. Endothelial activation, endothelial dysfunction and premature atherosclerosis in systemic autoimmune diseases.
Bijl M
Neth J Med; 2003 Sep; 61(9):273-7. PubMed ID: 14692439
[TBL] [Abstract][Full Text] [Related]
37. Cardiovascular disease in autoimmune rheumatic diseases.
Hollan I; Meroni PL; Ahearn JM; Cohen Tervaert JW; Curran S; Goodyear CS; Hestad KA; Kahaleh B; Riggio M; Shields K; Wasko MC
Autoimmun Rev; 2013 Aug; 12(10):1004-15. PubMed ID: 23541482
[TBL] [Abstract][Full Text] [Related]
38. [Rheumatic diseases and atherosclerosis: a role of rheological and microcirculatory impairments].
Shilkina NP
Angiol Sosud Khir; 2010; 16(2):23-9. PubMed ID: 21032869
[TBL] [Abstract][Full Text] [Related]
39. Oxidized low density lipoproteins: The bridge between atherosclerosis and autoimmunity. Possible implications in accelerated atherosclerosis and for immune intervention in autoimmune rheumatic disorders.
Suciu CF; Prete M; Ruscitti P; Favoino E; Giacomelli R; Perosa F
Autoimmun Rev; 2018 Apr; 17(4):366-375. PubMed ID: 29425936
[TBL] [Abstract][Full Text] [Related]
40. Proliferation signal inhibitors for the treatment of refractory autoimmune rheumatic diseases: a new therapeutic option.
Yoon KH
Ann N Y Acad Sci; 2009 Sep; 1173():752-6. PubMed ID: 19758225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
